Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Surgical Endoscopy
Erschienen in: Surgical Endoscopy 3/2011

01.03.2011 | Review

RETRACTED ARTICLE: Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy

verfasst von: Yoshitaka Fujii

Erschienen in: Surgical Endoscopy | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

The common and distressing complications of postoperative nausea and vomiting (PONV) are the main concern of 40–70% of patients undergoing laparoscopic cholecystectomy (LC). The first step in preventing PONV after LC is to reduce the risk factors involving patient characteristics, surgical procedure, anesthetic technique, and postoperative care. Particularly, the use of propofol-based anesthesia can reduce the incidence of PONV after LC. Second, prophylactic antiemetics including antihistamines (dimenhydrinate), phenothiazines (perphenazine), butyrophenones (droperidol), benzamides (metoclopramide), dexamethasone, and serotonin receptor antagonists (ondansetron, granisetron, tropisetron, dolasetron, and ramosetron) are available for preventing PONV after LC. Third, antiemetic therapy combined with a serotonin receptor antagonist (ondansetron, granisetron) and droperidol or dexamethasone is highly effective in the prevention of PONV after LC. Fourth, acupressure at the P6 point is a nonpharmacologic technique that is as effective as ondansetron for preventing PONV after LC. Knowledge regarding the risk factors for PONV and antiemetics is needed for the management of PONV after LC.
Literatur
1.
Cunningham AJ (1994) Laparoscopic surgery: anesthetic implications. Surg Endsc 8:1272–1284
2.
Cunningham AJ, Brull SJ (1993) Laparoscopic cholecystectomy: anesthetic implications. Anesth Analg 76:1120–1133PubMedCrossRef
3.
Rose DK, Choen MM, Soutter DI (1992) Laparoscopic cholecystectomy: the anaesthetist’s point of view. Can J Anaesth 39:809–815PubMedCrossRef
4.
Naguib M, el Bakry AK, Khoshim MH, Channa AB, el Gammal M, el Gammal K, Elhattab YS, Attia M, Jaroudi R, Saddique A (1996) Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo. Can J Anaesth 43:226–231PubMedCrossRef
5.
Jokela R, Koivuranta M (1999) Tropisetron or droperidol in the prevention of postoperative nausea and vomiting: a comparative, randomised, double-blind study in women undergoing laparoscopic cholecystectomy. Acta Anaesthesiol Scand 43:645–650PubMedCrossRef
6.
Wang JJ, Ho ST, Liu YH, Lee SC, Liu YC, Liano YC, Ho CM (1999) Dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy. Br J Anaesth 83:772–775PubMedCrossRef
7.
Watcha MF, White PF (1992) Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 77:162–170PubMedCrossRef
8.
Kovac AL (2000) Prevention and treatment of postoperative nausea and vomiting. Drugs 59:213–243PubMedCrossRef
9.
Borison HL, Wang SC (1953) Physiology and pharmacology of vomiting. Pharm Rev 5:192–230
10.
Wang SC, Borrison HL (1950) The vomiting center: a critical experimental analysis. Arch Neuro Psych 63:928–941CrossRef
11.
Apfel CC, Grein CA, Haubitz I, Goepfert C, Usadel J, Sefrin P, Roewer N (1998) A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol Scand 42:495–501PubMedCrossRef
12.
Sinclair DR, Chung F, Mezei G (1999) Can postoperative nausea and vomiting be predicted? Anesthesiology 91:109–118PubMedCrossRef
13.
Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N (1999) A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 91:693–700PubMedCrossRef
14.
Beattie WS, Lindblad T, Buckley DN, Forrest JB (1991) The incidence of postoperative nausea and vomiting in women undergoing laparoscopy is influenced by the day of menstrual cycle. Can J Anaesth 38:298–302PubMedCrossRef
15.
Smessaert A, Schehr CA, Artusio JF Jr (1959) Nausea and vomiting in the immediate postoperative period. JAMA 170:2072–2076CrossRef
16.
Hough MB, Sweeney BP (1998) The influence of smoking on postoperative nausea and vomiting. Anaesthesia 53:932–933PubMedCrossRef
17.
Sweeny BP (2002) Why does smoking protect against PONV? Br J Anaesth 89:810–813CrossRef
18.
Iitomi T, Toriumi S, Kondo A, Akazawa T, Nakahara T (1995) Incidence of nausea and vomiting after cholecystectomy performed via laparotomy or laparoscopy (Japanese). Masui 44:1727–1731
19.
Jenkins JC, Lahay D (1971) Central mechanisms of vomiting related to catecholamine response: anaesthetic implication. Can Anaesth Soc 18:434–441CrossRef
20.
Perreault L, Normandin N, Plamondon L, Blain R, Rousseau P, Girard M, Forget G (1982) Middle ear pressure variations during nitrous oxide and oxygen anaesthesia. Can Anaesth Soc J 29:428–434PubMedCrossRef
21.
Hartung J (1996) Twenty-four of twenty-seven studies show a greater incidence of emesis with nitrous oxide than alternative anesthetics. Anesth Analg 83:114–116PubMed
22.
Taylor E, Feinstein R, White PF, Soper N (1992) Anesthesia for laparoscopic cholecystectomy: is nitrous oxide contraindicated? Anesthesiology 76:541–543PubMedCrossRef
23.
Sneyd JR, Carr A, Byrom WD, Bilski AJT (1998) A mata-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur J Anaesthesiol 15:433–445PubMed
24.
Klockgether-Radke A, Piorek V, Crozier T, Kettler D (1996) Nausea and vomiting after laparoscopic surgery: a comparison of propofol and vomiting after laparoscopic surgery: a comparison of propofol and thiopentone/halothane anaesthesia. Eur J Anaesthesiol 13:3–9PubMedCrossRef
25.
Borgeat A, Wilder-Smith OHG, Saiah M, Rifat K (1992) Subhypnotic doses of propofol possess direct antiemetic properties. Anesth Analg 74:539–541PubMedCrossRef
26.
Ostman PL, Faure E, Glosten B, Kemen M, Robert MK, Bedwell S (1990) Is the antiemetic effect of the emulsion of propofol due to the lipid emulsion? Anesth Analg 71:536–540PubMed
27.
Bonica JJ, Crepps W, Monk B, Bennett B (1958) Postoperative nausea, retching and vomiting: evaluation of cyclizine (marezine) suppositories for treatment. Anesthesiology 19:432–540CrossRef
28.
Kranke P, Morin AM, Roewer N, Eberhart HJ (2002) Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a mata-analysis of randomized controlled trial. Acta Anaesthesiol Scand 46:238–244PubMedCrossRef
29.
Eberhart LH, Seeling W, Bopp TI, Morin AM, Georgieff M (1999) Dimenhydrinate for prevention of postoperative nausea and vomiting in female inpatients. Eur J Anaesthesiol 16:284–289PubMed
30.
Kothari SN, Boyd WC, Bottcher ML, Lambert PJ (2000) Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial inpatients undergoing laparoscopic cholecystectomy. Surg Endosc 14:926–929PubMedCrossRef
31.
Stwart DJ (1990) Cancer therapy, vomiting and antiemetics. Can J Physiol Pharmacol 68:304–313CrossRef
32.
Steinbrook RA, Gosnell JL, Freiberger D (1998) Prophylactic antiemetics for laparoscopic cholecystectomy: a comparison of perpherazine, droperidol plus ondansetron, and droperidol plus metoclopramide. J Clin Anesth 10:494–498PubMedCrossRef
33.
Loeser EA, Bennet G, Stanley TH, Marchin R (1979) Comparison of droperidol, haloperidol, and prochlorperazine as postoperative antiemetics. Can Anaesth Soc J 26:125–127PubMedCrossRef
34.
Helmy SA (1999) Prophylactic antiemetic efficacy of ondansetron in laparoscopic cholecystectomy under total intravenous anaesthesia: a randomized, double-blind comparison with droperidol, metoclopramide, and placebo. Anaesthesia 54:266–271PubMedCrossRef
35.
McCormick C (2002) FDA alert: current FDA report on droperidol status and basis for “black box” warning. Am Soc Anesthesiol Newslett 66:19–20
36.
Habib AS, Gan TJ (2003) Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 96:1377–1379PubMedCrossRef
37.
Harrington RA, Hamilton CW, Brogden RN, Linkwwich JA, Romankiewicz JA, Heel RC (1983) Metoclopramide: an update review of its pharmacological properties and clinical use. Drugs 25:451–494PubMedCrossRef
38.
Wilson EB, Bass CS, Abrameit W, Roberson R, Smith RW (2001) Metoclopramide versus ondansetron in prophylaxis of nausea and vomiting for laparoscopic cholecystectomy. Am J Surg 181:138–141PubMedCrossRef
39.
Quaynor H, Raeder JC (2002) Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies. Acta Anaesthesiol Scand 46:109–113PubMed
40.
Henzi I, Walder B, Tramer MR (2000) Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 99:186–194CrossRef
41.
Schimmer BP, Parler KL (2001) Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds) Goodman and Gilmann’s the pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 1649–1677
42.
Feo CV, Sortini D, Ragazzi R, DePalma M, Liboni A (2006) Randomized clinical trial of the effect of preoperative dexamethasone on nausea and vomiting after laparoscopic cholecystectomy. Br J Surg 93:295–299PubMedCrossRef
43.
Wang JJ, Ho ST, Uen YH, Lin MT, Chen KT, Huang JC, Tzeng JI (2002) Small-dose dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy: a comparison of tropisetron with saline. Anesth Analg 95:229–232PubMedCrossRef
44.
Cabrera JC, Matute E, Escolano F, Castillo J, Santiveri X, Castano J (1997) Efficacy of ondansetron in the prevention of nausea and vomiting after laparoscopic cholecystectomy (in Spanish). Rev Esp Anesthesiol Reanim 44:36–38
45.
Liberman MA, Howe S, Lane M (2000) Ondansetron versus placebo for prophylaxis of nausea and vomiting in patients undergoing ambulatory laparoscopic cholecystectomy. Am J Surg 179:60–62PubMedCrossRef
46.
Grover VK, Mathew PJ, Hegde H (2009) Efficacy of orally disintegrating ondansetron in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomised, double-blind placebo controlled study. Anaesthesia 64:595–600PubMedCrossRef
47.
Fujii Y, Saitoh Y, Tanaka H, Toyooka H (1998) Effective dose of granisetron in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecyectomy. Eur J Anaesthesiol 15:287–291PubMed
48.
Fujii Y, Tanaka H, Kawasaki T (2001) Prophylaxis with oral granisetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a prospective randomized study. Arch Surg 136:101–104PubMedCrossRef
49.
Piper SN, Suttner SW, Rohm KD, Maleck WH, Larbig E (2002) Dolasetron, but not metoclopramide prevents nausea and vomiting in patients undergoing laparoscopic cholecyetectomy. Can J Anesthesiol 49:1021–1028CrossRef
50.
Walker JB (2001) Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting. Clin Ther 23:932–938PubMedCrossRef
51.
Fujii Y, Uemura A, Tanaka H (2002) Prophylaxis of nausea and vomiting after laparoscopic cholecystectomy with ramosetron: randomised controlled trial. Eur J Surg 168:583–586PubMedCrossRef
52.
Bunce KT, Tyers MB (1992) The role of 5-HT in postoperative nausea and vomiting. Br J Anaesth 69:60S–62SPubMedCrossRef
53.
Rowbotham DJ (1992) Current management of postoperative nausea and vomiting. Br J Anaesth 69:46S–59SPubMedCrossRef
54.
Smith DB, Newlands ES, Rustin GJ, Begent RH, Howells N, McQuade B, Bagshawe KD (1991) Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 338:487–490PubMedCrossRef
55.
Youngs S (1981) Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone: roles of tryptophan catabolism and kynurenine synthesis. Br J Pharmacol 74:695–700CrossRef
56.
Frederikson M, Mursti T, Furst C, Steineck G, Borjeson S, Wikblom M (1992) Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br J Cancer 65:779–780CrossRef
57.
Sager S (1991) The current role of antiemetic drugs in oncology: a recent revolution in patient symptom control. Cancer Treat Rev 18:95–135CrossRef
58.
Award IT, Murphy D, Stack D, Swanton BJ, Meeke RI, Shorten GD (2002) A comparison of effects of droperidol and the combination of droperidol and ondansetron on postoperative nausea and vomiting for patients undergoing laparoscopic cholecystectomy. J Clin Anesth 14:481–485CrossRef
59.
Fujii Y, Saitoh Y, Tanaka H, Toyooka H (1998) Prophylactic antiemetic therapy with granisetron–droperidol combination in patients undergoing laparoscopic cholecystectomy. Can J Anaesth 45:541–544PubMedCrossRef
60.
Elhakim M, Nafie M, Mahmoud K, Atef A (2002) Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy. Can J Anesth 49:922–926PubMedCrossRef
61.
Fujii Y, Saitoh Y, Tanaka H, Toyooka H (2000) Granisetron/dexamethasone combination for the prevention of postoperative nausea and vomiting after laparoscopic cholecyetectomy. Eur J Anaesthesiol 17:64–68PubMed
62.
Lee A, Done ML (1999) The use of nonpharmacologic technique to prevent postoperative nausea and vomiting: a meta-analysis. Anesth Analg 88:1362–1369PubMed
63.
Agarwal A, Bose N, Gaur A, Singh U, Gupta MK, Singh D (2002) Acupressure and ondansetron for postoperative nausea and vomiting after laparoscopic cholecytectomy. Can J Anesth 49:554–560PubMedCrossRef
64.
Frey UH, Funk M, Lohleim C, Peters J (2009) Effect of P6 acustimulation on postoperative nausea and vomiting in patients undergoing a laparoscopic cholecystectomy. Acta Anaesthesiol Scand 53:1341–1347PubMedCrossRef
Metadaten
Titel
RETRACTED ARTICLE: Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy
verfasst von
Yoshitaka Fujii
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 3/2011
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-010-1193-9

Weitere Artikel der Ausgabe 3/2011

Surgical Endoscopy 3/2011 Zur Ausgabe

Review

New technologies for information retrieval to achieve situational awareness and higher patient safety in the surgical operating room: the MRI institutional approach and review of the literature

OriginalPaper

Long- and short-type double-balloon enteroscopy-assisted therapeutic ERCP for intact papilla in patients with a Roux-en-Y anastomosis

OriginalPaper

Endoscopic ultrasonography is valuable for identifying early gastric cancers meeting expanded-indication criteria for endoscopic submucosal dissection

Review

Surgery in space: the future of robotic telesurgery

Technique

Comparison of two actuation systems for laparoscopic surgical manipulators using motion analysis

OriginalPaper

Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.